Doximity, Inc. (DOCS) vs MiniMed Group, Inc. Common Stock (MMED)
A side-by-side comparison of Doximity, Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DOCS
Doximity, Inc.
$28.68HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
MMED
MiniMed Group, Inc. Common Stock
$19.71HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — DOCS vs MMED
growth of $100 · dividends reinvested · last 1yDOCS +9.6% (+9.6%/yr)MMED +9.0% (+9.0%/yr)DOCS compounded faster over this window
DOCS MMED
DOCS vs MMED: by the numbers
- •MMED is the larger company ($5.54B vs $5.36B market cap).
- •DOCS is profitable (25.48% net margin) while MMED runs a net loss (-10.21%).
Metrics side by side
Valuation
| Metric | DOCS | MMED |
|---|---|---|
| P/E ratio | 33.74 | N/A |
| Forward P/E | 21.29 | 29.27 |
| PEG ratio | 0.65 | N/A |
| P/S ratio | 8.18 | 1.72 |
| P/B ratio | 5.86 | 1.53 |
| EV / EBITDA | 24.10 | 30.79 |
| FCF yield | 5.58% | N/A |
Profitability
| Metric | DOCS | MMED |
|---|---|---|
| Gross margin | 88.07% | 53.85% |
| Operating margin | 29.60% | 0.53% |
| Net margin | 25.48% | -10.21% |
| ROE | 18.24% | -9.09% |
| ROIC | 15.35% | 0.43% |
Growth (annualized)
| Metric | DOCS | MMED |
|---|---|---|
| Revenue CAGR (5Y) | 21.94% | N/A |
| EPS CAGR (5Y) | 54.32% | N/A |
| FCF CAGR (5Y) | 23.75% | N/A |
| Total return CAGR (5Y) | -18.23% | N/A |
Frequently asked
- Is DOCS or MMED more profitable?
- DOCS runs the higher net margin — DOCS at 25.48% versus MMED at -10.21%.
Go deeper
Dig into the metrics
Doximity P/E ratioDoximity ROEMiniMed Group, Inc. Common Stock ROEDoximity operating marginMiniMed Group, Inc. Common Stock operating marginDoximity revenue growthMiniMed Group, Inc. Common Stock revenue growthDoximity free cash flowMiniMed Group, Inc. Common Stock free cash flow
Doximity & MiniMed Group, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.